Vincentage Pharma Co., Ltd
Clinical trials sponsored by Vincentage Pharma Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill aims to tackle high blood pressure and weight together Results expected Oct 2026 (estimated)
-
New pill aims to tackle high blood pressure and weight together
Disease control OngoingThis study tests a new drug called VCT220 in 160 adults with high blood pressure who are also overweight or obese. Participants will take either VCT220 or a placebo pill for 20 weeks. The main goal is to see if VCT220 can safely lower blood pressure more than a placebo.
Phase 2 • Sponsor: Vincentage Pharma Co., Ltd • Aim: Disease control
Last updated Sep 21, 2026 19:00 UTC
-
Healthy volunteers test new pill for obesity and diabetes – but only to see how food changes its effects
Knowledge-focused OngoingThis early-stage study looks at how taking a new tablet called CX11 with or without food changes the amount of drug in the blood. It involves 32 healthy adults and does not aim to treat any disease. The results will help researchers decide how to give the drug in future studies f…
Phase 1 • Sponsor: Vincentage Pharma Co., Ltd • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC